Charles River Laboratories
300 hedge funds and large institutions have $4.2B invested in Charles River Laboratories in 2017 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 100 increasing their positions, 129 reducing their positions, and 28 closing their positions.
43% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 28
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
19% more capital invested
Capital invested by funds: $3.52B → $4.2B (+$681M)
1.03% more ownership
Funds ownership: 97.64% → 98.67% (+1%)
1% more funds holding
Funds holding: 297 → 300 (+3)
19% less call options, than puts
Call options by funds: $1.67M | Put options by funds: $2.05M
22% less repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 129
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$324M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$60.1M |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
+$41.1M |
| 4 |
Morgan Stanley
New York
|
+$35.1M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$24.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$35.7M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$19.1M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$16M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$14.1M |
| 5 |
Millennium Management
New York
|
-$14.1M |
CRL Hedge Fund Activity: Q1 2017 in Review
300 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2017, worth a combined $4.2B — up 19% from $3.52B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new CRL positions and 28 closed out — a net gain of 12 holders — while 100 added to existing stakes and 129 trimmed.
The largest buyer was BlackRock, adding an estimated $324M. The largest seller was Marshall Wace, exiting entirely with an estimated $35.7M sold.
- 300 institutional investors held Charles River Laboratories (CRL) as of Q1 2017, up from 297 in Q4 2016.
- Funds reported $4.2B of Charles River Laboratories stock for Q1 2017, up 19% quarter-over-quarter.
- 40 funds opened new Charles River Laboratories positions in Q1 2017 and 28 closed out, a net change of +12 holders.
- The largest Charles River Laboratories buyer in Q1 2017 was BlackRock, an estimated $324M added.
- The largest Charles River Laboratories seller in Q1 2017 was Marshall Wace, an estimated $35.7M sold.
Based on aggregated 13F filings for Q1 2017.